Adoptive T cell therapy cures mice from active hemophagocytic lymphohistiocytosis (HLH)

Primary hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome caused by impaired lymphocyte cytotoxicity. First‐line therapeutic regimens directed against activated immune cells or secreted cytokines show limited efficacy since they do not target the underlying immunological probl...

Descripción completa

Detalles Bibliográficos
Autores principales: Weißert, Kristoffer, Ammann, Sandra, Kögl, Tamara, Dettmer‐Monaco, Viviane, Schell, Christoph, Cathomen, Toni, Ehl, Stephan, Aichele, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728053/
https://www.ncbi.nlm.nih.gov/pubmed/36278424
http://dx.doi.org/10.15252/emmm.202216085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728053/
https://www.ncbi.nlm.nih.gov/pubmed/36278424
http://dx.doi.org/10.15252/emmm.202216085

Ejemplares similares